These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31711580)

  • 1. Early Aspirin Nonresponders Identification by Routine Use of Aggregometry Test in Patients With Left Ventricle Assist Devices Reduces the Risk of Pump Thrombosis.
    Montalto A; Comisso M; Cammardella A; Nicolò F; Gherli R; Palermo A; Pulcinelli F; Musumeci F
    Transplant Proc; 2019 Nov; 51(9):2986-2990. PubMed ID: 31711580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin resistance in patients with ventricular assist devices: A follow-up study.
    Flieder T; Blaesen S; Schulte K; Blasberg J; Lauenroth V; Knabbe C; Schramm R; Morshuis M; Gummert J; Birschmann I
    Artif Organs; 2024 Jul; 48(7):781-788. PubMed ID: 38553978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
    Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
    J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pump Thrombosis following HeartMate II Left Ventricular Assist Device Implantation in a Patient with Aspirin and Plavix Resistance.
    Ghodsizad A; Badiye A; Zeriouh M; Pae W; Koerner MM; Loebe M
    Heart Surg Forum; 2016 Dec; 19(6):E284-E285. PubMed ID: 28054898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis in continuous-flow left ventricular assist devices: pathophysiology, prevention, and pharmacologic management.
    Jennings DL; Weeks PA
    Pharmacotherapy; 2015 Jan; 35(1):79-98. PubMed ID: 25329333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
    Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
    J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of device thrombus in the HeartWare HVAD: Success and outcomes depend significantly on the initial treatment strategy.
    Stulak JM; Dunlay SM; Sharma S; Haglund NA; Davis MB; Cowger J; Shah P; Masood F; Aaronson KD; Pagani FD; Maltais S
    J Heart Lung Transplant; 2015 Dec; 34(12):1535-41. PubMed ID: 26681123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Assist Device Malfunctions: It Is More Than Just the Pump.
    Kormos RL; McCall M; Althouse A; Lagazzi L; Schaub R; Kormos MA; Zaldonis JA; Sciortino C; Lockard K; Kuntz N; Dunn E; Teuteberg JJ
    Circulation; 2017 Oct; 136(18):1714-1725. PubMed ID: 28674109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the optimal anticoagulation in patients with a left ventricular assist device?
    Rossi M; Serraino GF; Jiritano F; Renzulli A
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Bleeding and Thrombosis Based on Aspirin Responsiveness after Continuous-Flow Left Ventricular Assist Device Placement.
    Floroff CK; Rieger KL; Veasey TM; Strout SE; DeNino WF; Meadows HB; Stroud MR; Toole JM; Heyward DP; Brisco-Bacik MA; Cook JL; Lazarchick J; Uber WE
    ASAIO J; 2017; 63(5):578-587. PubMed ID: 28134659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is anti-platelet therapy needed in continuous flow left ventricular assist device patients? A single-centre experience.
    Litzler PY; Smail H; Barbay V; Nafeh-Bizet C; Bouchart F; Baste JM; Abriou C; Bessou JP
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):55-9; discussion 59-60. PubMed ID: 23671203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation.
    Xanthopoulos A; Tryposkiadis K; Triposkiadis F; Fukamachi K; Soltesz EG; Young JB; Wolski K; Blackstone EH; Starling RC
    J Am Heart Assoc; 2020 Jul; 9(14):e015897. PubMed ID: 32648508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device.
    Klodell CT; Massey HT; Adamson RM; Dean DA; Horstmanshof DA; Ransom JM; Salerno CT; Cowger JA; Aranda JM; Chen L; Long JW; Dembitsky W
    J Card Surg; 2015 Oct; 30(10):775-80. PubMed ID: 26283153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches.
    Saeed D; Maxhera B; Albert A; Westenfeld R; Hoffmann T; Lichtenberg A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):90-5. PubMed ID: 26993475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events.
    Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS
    ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational characterization of flow and blood damage potential of the new maglev CH-VAD pump versus the HVAD and HeartMate II pumps.
    Zhang J; Chen Z; Griffith BP; Wu ZJ
    Int J Artif Organs; 2020 Oct; 43(10):653-662. PubMed ID: 32043405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.
    Majeed F; Kop WJ; Poston RS; Kallam S; Mehra MR
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):147-57. PubMed ID: 19174824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.